Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × talazoparib × Clear all

NCT04068831 2024-12-27

Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma

Phase 2 Completed

18 enrolled 9 charts

Carcinoma, Renal Cell